Closing Bell: Knight Therapeutics Inc down on Tuesday (GUD)
Today in trading, shares of Knight Therapeutics Inc opened at $5.70 and closed at $5.69. Intraday prices ranged from a low of $5.65 to a high of $5.71.
Shares eased -0.18 percent from the previous day's close of $5.70.
Today across North America, the TSX Composite closed -0.26% at 22813.75, the S&P 500 closed 1.08% at 5564.41, the Dow Jones Industrial Average closed 0.32% at 40415.44 and the Nasdaq Composite closed 1.58% at 18007.57.
Knight Therapeutics Inc traded under GUD on the Toronto Stock Exchange (TSX).
A total of 29,859 shares was traded during the session, with total trades of 232, while having an average volume of 47,878 in the last five days.
The TSX overall saw 3,093 price advancers against 2,137 declines and 96 unchanged.
During the prior 52 weeks, GUD.TO has traded as high as $6.22 (May 15,2024) and low as $4.35 (October 23,2023). Moreover, the shares have advanced 16.60% in the last 52 weeks, while they have boosted 9.63% year-to-date.
Following today's trading, Knight Therapeutics Inc has a market capitalization of $577.84 million on a float of 101,376 shares outstanding. Its annual EPS is $-0.16.
Knight Therapeutics Inc is a TSX Drug Specialty & Generic company headquartered in Montreal, CAN.
Knight Therapeutics Inc's average recommendation is "Moderate Buy" based on 4.00 analysts according to Zacks. Currently, there are 3 buy ratings and 1 hold ratings for the stock.
AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..
